Advantia Health

advantiahealth.com

Advantia Health is an innovative fast growing healthcare delivery company, founded and led by a passionate group of entrepreneurs and backed by top tier healthcare investors. Sean Glass, Founder & CEO of Advantia Health, previously founded and grew a financial technology company to more than a billion dollar valuation. Advantia Health provides high quality, high value care using technology and highly efficient outpatient facilities. In a little over three years, the company has grown to serve more than 100,000 customers and is on a path to serving many more in the years to come. Advantia’s investors include Deerfield Management, Life Force Capital, and individuals with significant health care, technology, and finance expertise.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

news image

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More

COVID-19 BRINGS DIVISIONS ON HYDROXYCHLOROQUINE, REOPENING

Fiercepharma | May 19, 2020

news image

Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate. As the pandemic plays out, political divisions have unfolded around hydroxychloroquine and reopening economies, for starters. At center stage last week was a House hearing over ousted Biomedical Advanced Research and Development Authority (BARDA) Director Rick Bright’s whistleblower complaint. While...

Read More

Pharmacy Market

AIKIDO PHARMA REPORTS IMPROVED MANUFACTURING PROCESS AND NEW UNITED STATES PATENT FOR PANCREATIC DRUG

AIkido Pharma Inc. | March 04, 2022

news image

AIkido Pharma Inc.reported an improvement in the manufacturing process for its pancreatic cancer drug, DHA-dFdC, licensed from the University of Texas at Austin. The Company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug. With respect to manufacturing process, the Company reported the successful development of a new means for the scaled pro...

Read More

Business Insights

AGILENT ANNOUNCES THE INNOVATIVE SEAHORSE XF PRO ANALYZER

Agilent Technologies Inc. | January 25, 2022

news image

Agilent Technologies Inc. announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools. With enhanced performance, more robust and efficient workflows, and an optimized user experience, the XF Pro enables operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fate, fitness, and function. Preclinical th...

Read More
news image

Business Insights

BASETWO LAUNCHES NO-CODE ARTIFICIAL INTELLIGENCE PLATFORM FOR PHARMACEUTICAL MANUFACTURING, RAISES $3.8 MILLION

Basetwo | May 27, 2022

Basetwo, a SaaS AI platform for manufacturers, announced it secured a $3.8M seed round led by Glasswing Ventures and Argon Ventures with additional funding from Caffeinated Capital, Graphite Ventures, MaRs IAF, Pareto Holdings, Plug and Play, and Quiet Capital. The funding supports the launch of the category-making Basetwo AI platform, a first-of-its-kind solution that enables process engineers to rapidly build digital twins of their manufacturing plants leveraging a familiar no-c...

Read More
news image

COVID-19 BRINGS DIVISIONS ON HYDROXYCHLOROQUINE, REOPENING

Fiercepharma | May 19, 2020

Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate. As the pandemic plays out, political divisions have unfolded around hydroxychloroquine and reopening economies, for starters. At center stage last week was a House hearing over ousted Biomedical Advanced Research and Development Authority (BARDA) Director Rick Bright’s whistleblower complaint. While...

Read More
news image

Pharmacy Market

AIKIDO PHARMA REPORTS IMPROVED MANUFACTURING PROCESS AND NEW UNITED STATES PATENT FOR PANCREATIC DRUG

AIkido Pharma Inc. | March 04, 2022

AIkido Pharma Inc.reported an improvement in the manufacturing process for its pancreatic cancer drug, DHA-dFdC, licensed from the University of Texas at Austin. The Company also reported the issuance of an additional U.S. patent covering the drug, and the filing of a continuation patent application intended to expand patent coverage to other facets of the drug. With respect to manufacturing process, the Company reported the successful development of a new means for the scaled pro...

Read More
news image

Business Insights

AGILENT ANNOUNCES THE INNOVATIVE SEAHORSE XF PRO ANALYZER

Agilent Technologies Inc. | January 25, 2022

Agilent Technologies Inc. announced the release of the Agilent Seahorse XF Pro Analyzer, featuring new pharma-oriented workflow solutions incorporating advanced experimental design and analysis tools. With enhanced performance, more robust and efficient workflows, and an optimized user experience, the XF Pro enables operators at any skill level to access the most advanced cellular metabolism analysis technology for understanding cellular fate, fitness, and function. Preclinical th...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us